NFKB1 and fatty liver disease: An earlier study reported that low-grade systemic inflammation, also known as “metabolic inflammation” and “sub-acute inflammation”, plays an important role in developing insulin resistance and hepatic steatosis in mice activating NF-κB signaling pathways (Zeng et al., 2016).